Tech Company Financing Transactions

Aquinox Pharmaceuticals Funding Round

Aquinox Pharmaceuticals, operating out of Vancouver BC, received $25 million in investment from Ventures West, Baker Brothers Investments and BC Advantage Funds.

Transaction Overview

Company Name
Aquinox Pharmaceuticals
Announced On
6/17/2010
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

Ventures West (Lead Investor) (Kenneth Galbraith)

Baker Brothers Investments (Felix Baker)

BC Advantage Funds

Johnson & Johnson Development Corporation (Asish Xavier)

Pfizer Venture Investments (Elaine Jones)

Proceeds Purpose
The proceeds of the financing will allow Aquinox to advance its lead clinical candidate from its SH2-containing inositol-5'-phosphatase ("SHIP1") agonist program, AQX-1125, into Phase I and Phase II clinical studies. The financing will also enable Aquinox to continue drug discovery efforts towards the nomination of a second clinical candidate and additional pipeline candidates from its SHIP1 program.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
887 Great Northern Way 450
Vancouver BC, V5T 4T5
Canada
Phone
(604) 629-9223
Website
www.aqxpharma.com
Email Address
[email protected]
Overview
Aquinox is a venture-backed pharmaceutical company and world leader in the discovery and development of novel, first-in-class, small molecules against SHIP1.
Profile
Aquinox Pharmaceuticals LinkedIn Company Profile
Social Media
Aquinox Pharmaceuticals Company Twitter Account
Company News
Aquinox Pharmaceuticals News
Facebook
Aquinox Pharmaceuticals on Facebook
YouTube
Aquinox Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Main
  David Main LinkedIn Profile  David Main Twitter Account  David Main News  David Main on Facebook
Chief Financial Officer
Kamran Alam
  Kamran Alam LinkedIn Profile  Kamran Alam Twitter Account  Kamran Alam News  Kamran Alam on Facebook
Chief Medical Officer
Barbara Troupin
  Barbara Troupin LinkedIn Profile  Barbara Troupin Twitter Account  Barbara Troupin News  Barbara Troupin on Facebook
Chief Operating Officer
Abigail Jenkins
  Abigail Jenkins LinkedIn Profile  Abigail Jenkins Twitter Account  Abigail Jenkins News  Abigail Jenkins on Facebook
VP - Bus. Development
Paul Brennan
  Paul Brennan LinkedIn Profile  Paul Brennan Twitter Account  Paul Brennan News  Paul Brennan on Facebook
VP - Bus. Development
Lloyd Mackenzie
  Lloyd Mackenzie LinkedIn Profile  Lloyd Mackenzie Twitter Account  Lloyd Mackenzie News  Lloyd Mackenzie on Facebook
VP - Human Resources
Shelley McCloskey
  Shelley McCloskey LinkedIn Profile  Shelley McCloskey Twitter Account  Shelley McCloskey News  Shelley McCloskey on Facebook
VP - Operations
David Green
  David Green LinkedIn Profile  David Green Twitter Account  David Green News  David Green on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/17/2010: SafetyWeb venture capital transaction
Next: 6/18/2010: IncellDx venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.